↓ Skip to main content

Combining energy-based focal ablation and immune checkpoint inhibitors: preclinical research and clinical trials

Overview of attention for article published in Frontiers in oncology, May 2023
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

twitter
4 X users

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
19 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Combining energy-based focal ablation and immune checkpoint inhibitors: preclinical research and clinical trials
Published in
Frontiers in oncology, May 2023
DOI 10.3389/fonc.2023.1153066
Pubmed ID
Authors

Minhan Jiang, Steven Fiering, Qi Shao

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 19 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 19 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 8 42%
Researcher 4 21%
Professor 1 5%
Student > Postgraduate 1 5%
Student > Doctoral Student 1 5%
Other 0 0%
Unknown 4 21%
Readers by discipline Count As %
Unspecified 8 42%
Medicine and Dentistry 4 21%
Biochemistry, Genetics and Molecular Biology 2 11%
Agricultural and Biological Sciences 1 5%
Unknown 4 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 May 2023.
All research outputs
#16,536,708
of 26,171,302 outputs
Outputs from Frontiers in oncology
#5,707
of 22,919 outputs
Outputs of similar age
#213,436
of 415,834 outputs
Outputs of similar age from Frontiers in oncology
#232
of 1,166 outputs
Altmetric has tracked 26,171,302 research outputs across all sources so far. This one is in the 36th percentile – i.e., 36% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,919 research outputs from this source. They receive a mean Attention Score of 3.1. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 415,834 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,166 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 79% of its contemporaries.